Life Science VC Firm 5AM Ventures Raising $240 Million for New Fund
Life science venture investor 5AM Ventures disclosed in a regulatory filing on Thursday that it is raising $240 million for a new fund. The Menlo Park firm founded by Andrew Schwab focuses on seed and early stage investments. Its portfolio includes Burlingame-based Biodesy, a company with a protein function analysis tool that raised $15 million on Thursday and named Greg Yap as its CEO.
Help employers find you! Check out all the jobs and post your resume.